New York State Licenses Personalized Prescribing DNA TestsThe New York State Department of Health Genelex Corporation DNA Drug Sensitivity testing has been licensed for use by physicians in the state. The issued Clinical Laboratory Permit for DNA testing of three enzymes, the cytochrome P450 enzymes, this process is more than 50 % of the most commonly prescribed medications. Research shows the majority of patients have one or more defects in the genetic coding for these enzymes, greatly increasing their risk of treatment failure or potentially life-threatening side effects. This is an important advance for personalized medicine in New York, especially for the 100,000 or more patients who live there and deny their Plavix treatment, said Howard Coleman, Genelex.
The body hostile to this type of implant and the sensors degrade over time, says Pishko. For these applications, the sensors only need work for a short period of time. Even for the soldiers, 24 to 72 hours is sufficient. . The U.S. Army funded this research.A’ndrea Elyse Messer 814-865-9481 Penn State science.To prostate cancer to grow to grow this male sexual hormone testosterone prostate tumors. Surgery or other hormones may be used to reduce the production of testosterone or block. Some men are hormone refractory prostate cancer ie the prostate cancer cells grow further, in spite of testosterone suppression. Different treatments are need for men with this kind of cancer.